By Editor , 28 September 2026
Cuvo Health Report: Only 14 States Ease Telehealth Licensing

Wilmington, Del. – September 27, 2026 -- A new 51-jurisdiction dataset from Cuvo Health shows that only 14 states offer out-of-state physicians a telehealth registration or telemedicine license short of full licensure, exposing a costly compliance gap for digital health startups seeking national scale.

By Editor , 27 September 2026
Accuray, Samsung NeuroLogica Partner on CyberKnife Volumetric Imaging

Madison, Wis. – September 27, 2026 -- Accuray Incorporated (NASDAQ: ARAY) has signed agreements with Samsung HME America's NeuroLogica Corp. unit to pursue advanced volumetric imaging capabilities for its CyberKnife System, the companies announced at the ASTRO Annual Meeting in Boston.

By Editor , 27 September 2026
Fuse Oncology to Showcase GE HealthCare iRT-S!GNAL Workflow at ASTRO 2026

Boone, N.C. – September 27, 2026 -- Fuse Oncology plans to demonstrate a potential integration linking GE HealthCare's Intelligent Radiation Therapy (iRT) software to its S!GNAL charge capture platform at the ASTRO 2026 Annual Meeting, running September 27-29 in Boston at booth 2533.

By Editor , 27 September 2026

Shanghai – September 26, 2026 -- IASO Biotechnology reported a 90% objective response rate and 90% minimal residual disease (MRD) negativity rate for its BCMA-targeted in vivo CAR-T therapy IASO206, generated via a single intravenous infusion without lymphodepleting chemotherapy, in first-in-human Phase 1 data presented as a late-breaking oral session (LBA-11) at the 2026 International Myeloma Society Annual Meeting.

By Editor , 26 September 2026
Farm Aid 2026 Spotlights Farm Bankruptcies Up 46% Amid Land Pressure

Virginia Beach – – September 26, 2026 -- Farm Aid 2026 drew a national spotlight to America's family farmers on Saturday, staged at Veterans United Home Loans Amphitheater as Chapter 12 farm bankruptcies rose 46% in 2025 and roughly 15,000 farms closed nationwide.

By Editor , 26 September 2026
STEMREGEN Ranks No. 332 on Inc. 5000 With 1,017% Growth

Whitefish, Mont. – September 25, 2026 -- STEMREGEN, a maker of science-backed stem cell supplements, has landed at No. 332 on the 2026 Inc. 5000 list after posting 1,017% revenue growth over three years, far outpacing the list's 130% median.

Company secures third straight Inc. 5000 ranking as growth trajectory accelerates

STEMREGEN previously ranked No. 265 in 2025 and No. 1,765 in 2024, marking three consecutive years on the annual list of America's fastest-growing private companies. The 2026 ranking measures revenue growth from 2022 through 2025.